vaccines manufacturing
Inside Piramal’s $7.95M Buyout of Biologics CDMO Yapan Bio
Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635) announced on August 18 that it has completed the acquisition of an incremental 40.67% stake in Yapan Bio Private Limited, a Hyderabad-based contract development and manufacturing organization (CDMO) specializing in vaccines and biologics, for aggregate cash consideration of 76 crore rupees, or roughly $7.95 million. The purchase brings…
